Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.

MLA

Grigg, Andrew, et al. “Safety and Efficacy of Obinutuzumab with CHOP or Bendamustine in Previously Untreated Follicular Lymphoma.” Haematologica, vol. 102, no. 4, Apr. 2017, pp. 765–72. EBSCOhost, https://doi.org/10.3324/haematol.2016.152272.

APA

Grigg, A., Dyer, M. J. S., Díaz, M. G., Dreyling, M., Rule, S., Lei, G., Knapp, A., Wassner-Fritsch, E., & Marlton, P. (2017). Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma. Haematologica, 102(4), 765–772. https://doi.org/10.3324/haematol.2016.152272

Chicago

Grigg, Andrew, Martin J S Dyer, Marcos González Díaz, Martin Dreyling, Simon Rule, Guiyuan Lei, Andrea Knapp, Elisabeth Wassner-Fritsch, and Paula Marlton. 2017. “Safety and Efficacy of Obinutuzumab with CHOP or Bendamustine in Previously Untreated Follicular Lymphoma.” Haematologica 102 (4): 765–72. doi:10.3324/haematol.2016.152272.